- News & Analysis
Page 661
Xcell extends funding by $12m
The Illumina-backed cellular technology developer has closed $12m in a series A round led by HBM Genomics.
Feb 17, 2017Rhythm reaches mezzanine stage to raise $41m
Pfizer and Ipsen returned to reinvest in the metabolic disorder treatment developer, which has now raised $114m altogether.
Feb 17, 2017Corporates treat MClinica to $6.3m
Globe Telecom, IMJ and Telkom Indonesia have committed capital to a $6.3m series A round for MClinica, the developer of a platform that connects pharmacies.
Feb 16, 2017Ceres Nanosciences traps initial $3m
George Mason University spinout Ceres Nanosciences has closed a first tranche of its $9m series A round.
Feb 15, 2017Mercer generates two spinouts
Mercer University has established SynPloid and DD Therapeutics that are each set to commercialise a drug delivery system.
Feb 15, 2017Mayo Clinic keeps Sensely company for series B
Sensely, the developer of a virtual nurse, has raised $8m in a funding round led by Chengwei Capital that featured healthcare company Mayo Clinic.
Feb 15, 2017Forerunner Medical crosses series B finish line
Existing investor WuXi PharmaTech took part in a round for the medical device developer that was led by a joint venture formed by Medtronic and Sequoia Capital.
Feb 14, 2017IDG Ventures samples SigTuple in $5.8m round
SigTuple, developer of a digital pathology system, has netted IDG Ventures India as an investor as part of a $5.8m series A round.
Feb 13, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin